First elected: 2017
Year of birth: 1948
Erik Hedlund has a long career in Ericsson, Siemens Medical and Saab-Scania Combitech, among others before focusing on staring new and developing existing companies, mainly in radiation therapy for cancer. Two of these companies, RaySearch Laboratories AB and C-Rad AB, are traded on Nasdaq Stockholm’s main list. Erik holds a Master of Science in Electrical and Systems Engineering at the Royal Institute of Technology and a degree in Economics from Stockholm university.
Independence: Independent of the Company and the Executive Management and independent of major shareholders
Other Board Assignments: Chariman Nolsterby Invest AB, Chariman hh Design AB
Holdings: 320 128 shares (indirect).